Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Leases (2020 - 2025)

AVITA Medical filings provide 6 years of Leases readings, the most recent being $2.9 million for Q4 2025.

  • On a quarterly basis, Leases fell 18.82% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 18.82% decrease, with the full-year FY2025 number at $2.9 million, down 18.82% from a year prior.
  • Leases hit $2.9 million in Q4 2025 for AVITA Medical, down from $3.1 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $3.9 million in Q2 2024 to a low of $851000.0 in Q4 2022.
  • Median Leases over the past 5 years was $2.1 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Leases: tumbled 44.88% in 2022 and later skyrocketed 186.72% in 2023.
  • AVITA Medical's Leases stood at $1.5 million in 2021, then tumbled by 44.88% to $851000.0 in 2022, then soared by 186.72% to $2.4 million in 2023, then surged by 46.35% to $3.6 million in 2024, then fell by 18.82% to $2.9 million in 2025.
  • The last three reported values for Leases were $2.9 million (Q4 2025), $3.1 million (Q3 2025), and $3.1 million (Q2 2025) per Business Quant data.